Lonza, Antharis partner to develop next-generation dual-payload ADCs for GI cancers
Exclusive licensing agreement combines Lonza’s dual-payload ADC technology with Antharis’ antibody engineering expertise
Exclusive licensing agreement combines Lonza’s dual-payload ADC technology with Antharis’ antibody engineering expertise
Subscribe To Our Newsletter & Stay Updated